Development of a personalized bidirectional text messaging tool for HIV adherence assessment and intervention among substance abusers

Journal of Substance Abuse Treatment

Volumn 46, Issue 1, 2014, Pages 66-73

  Ingersoll, Karen ^a   Dillingham, Rebecca ^a   Reynolds, George ^b   Hettema, Jennifer ^a   Freeman, Jason ^a   Hosseinbor, Sharzad ^a   Winstead Derlega, Chris ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Health Decision Technologies LLC   (United States)

Author keywords

HIV adherence; Intervention; MHealth; Substance abuse; Text messaging

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ABSTINENCE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AUTOMATION; BEHAVIOR; DEPRESSION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MOBILE PHONE; MOOD; PATIENT COMPLIANCE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SELF CONCEPT; SUBSTANCE ABUSE; TEXT MESSAGING; TREATMENT REFUSAL;

HIV ADHERENCE; INTERVENTION; MHEALTH; SUBSTANCE ABUSE; TEXT MESSAGING;

ADULT; AFFECT; ANTI-HIV AGENTS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; REMINDER SYSTEMS; SUBSTANCE-RELATED DISORDERS; TEXT MESSAGING;

EID: 84886796060     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2013.08.002     Document Type: Article

References (46)

1. Babor, T. F., de la Fuente, J. R., Saunders, J., & Grant, M. (2001). AUDIT. the alcohol use disorders identification test. guidelines for use in primary health care, 2nd edition.
2. Berg K.M., Cooperman N.A., Newville H., Arnsten J.H. Self-efficacy and depression as mediators of the relationship between pain and antiretroviral adherence. AIDS Care 2009, 21:244-248. 10.1080/09540120802001697.
3. Brenner J. Pew internet: Mobile in the Pew Internet and American life project Retrieved July 4, 2013, from. http://www.pewinternet.org/Commentary/2012/February/Pew-Internet-Mobile.aspx.
4. Carrico A.W., Riley E.D., Johnson M.O., Charlebois E.D., Neilands T.B., Remien R.H., et al. Psychiatric risk factors for HIV disease progression: The role of inconsistent patterns of antiretroviral therapy utilization. Journal of Acquired Immune Deficiency Syndromes (1999) 2011, 56:146-150. doi:10.1097/QAI.0b013e318201df63; 10.1097/QAI.0b013e318201df63.
5. Chesney M. Adherence to HAART regimens. AIDS Patient Care and STDs 2003, 17:169-177. 10.1089/108729103321619773.
6. Cornelius J.B., Dmochowski J., Boyer C., St Lawrence J., Lightfoot M., Moore M. Text-messaging-enhanced HIV intervention for African American adolescents: A feasibility study. The Journal of the Association of Nurses in AIDS Care: JANAC 2012, 10.1016/j.jana.2012.06.005.
7. da Costa T.M., Barbosa B.J., Gomes e Costa D.A., Sigulem D., de Fatima Marin H., Filho A.C., et al. Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. International Journal of Medical Informatics 2012, 81:257-269. http://dx.doi.org/10.1016/j.ijmedinf.2011.10.002.
8. Daughters S.B., Magidson J.F., Schuster R.M., Safren S.A. ACT HEALTHY: A combined cognitive-behavioral depression and medication adherence treatment for HIV-infected substance users. Cognitive and Behavioral Practice 2010, 17:309-321.
9. Delgado S, Brant J, Rafaly M, White J, Freeman J, Sinha T, et al. (2009). Promoting adherence to HIV care in rural virginia through the development of an individualized short message service (SMS) delivery application. 4th International Conference on HIV Treatment and Adherence" International Association of Physicians in AIDS Care, Miami, FL.
10. Dowshen N., Kuhns L.M., Johnson A., Holoyda B.J., Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: A pilot study using personalized, interactive, daily text message reminders. Journal of Medical Internet Research 2012, 14:e51. 10.2196/jmir.2015; 10.2196/jmir.2015.
11. Fagerstrom K. Determinants of tobacco use and renaming the FTND to the Fagerstrom test for cigarette dependence. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco 2011, 10.1093/ntr/ntr137.
12. Farrell Carnahan L., Fabbri S., Ingersoll K. Technicalities: Getting and staying connected to people living with HIV/AIDS in the southern United States. Patient Education and Counseling 2011, 83:139-140. author reply 141. 10.1016/j.pec.2010.06.036.
13. Flandre P., Peytavin G., Meiffredy V., Saidi Y., Descamps D., Delagnes M., et al. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial. Antiviral Therapy 2002, 7:113-121.
14. Gavin D.R., Ross H.E., Skinner H.A. Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. British Journal of Addiction 1989, 84:301-307.
15. González-Guarda R.M., McCabe B.E., Florom-Smith A., Cianelli R., Peragallo N. Substance abuse, violence, HIV, and depression: An underlying syndemic factor among Latinas. Nursing Research 2011, 60:182.
16. Horvath T., Azman H., Kennedy G.E., Rutherford G.W. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database of Systematic Reviews (Online) 2012, 3:CD009756. http://dx.doi.org/10.1002/14651858.CD009756.
17. Ingersoll K.S., Farrell-Carnahan L., Cohen-Filipic J., Heckman C.J., Ceperich S.D., Hettema J., et al. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+crack cocaine users. Drug and Alcohol Dependence 2011, 116:177-187. 10.1016/j.drugalcdep.2010.12.016.
18. Kempf M.C., McLeod J., Boehme A.K., Walcott M.W., Wright L., Seal P., et al. A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern united states: Implications for targeted interventions. AIDS Patient Care and STDs 2010, 10.1089/apc.2010.0065.
19. Konkle-Parker D.J., Erlen J.A., Dubbert P.M. Barriers and facilitators to medication adherence in a southern minority population with HIV disease. Journal of the Association of Nurses in AIDS Care 2008, 19(2):98-104.
20. Leite L., Buresh M., Rios N., Conley A., Flys T., Page K.R. Cell phone utilization among foreign-born Latinos: A promising tool for dissemination of health and HIV information. Journal of Immigrant and Minority Health/Center for Minority Public Health 2013, 10.1007/s10903-013-9792-x.
21. Lenhart A., Ling R., Campbell S., Purcell K. Teens and mobile phones. . Washington, D.C.: Pew Research Center Retrieved from. http://pewinternet.org/~/media//Files/Reports/2010/PIP-Teens-and-Mobile-2010-with-topline.pdf.
22. Lewis M.A., Uhrig J.D., Bann C.M., Harris J.L., Furberg R.D., Coomes C., et al. Tailored text messaging intervention for HIV adherence: A proof-of-concept study. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association 2013, 32:248-253. 10.1037/a0028109; 10.1037/a0028109.
23. Malta M., Strathdee S.A., Magnanini M.M., Bastos F.I. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction (Abingdon, England) 2008, 103:1242-1257. 10.1111/j.1360-0443.2008.02269.x.
24. Mbuagbaw L., Thabane L., Ongolo-Zogo P., Lester R.T., Mills E.J., Smieja M., et al. The Cameroon Mobile Phone SMS (CAMPS) trial: A randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One 2012, 7:e46909. http://dx.doi.org/10.1371/journal.pone.0046909.
25. Miller W.R., Rollnick S. Motivational interviewing 2013, Guilford Press, New York.
26. Moyers T.B., Martin T., Houck J.M., Christopher P.J., Tonigan J.S. From in-session behaviors to drinking outcomes: A causal chain for motivational interviewing. Journal of Consulting and Clinical Psychology 2009, 77:1113-1124. 10.1037/a0017189.
27. Mugavero M.J., Lin H.Y., Allison J.J., Giordano T.P., Willig J.H., Raper J.L., et al. Racial disparities in HIV virologic failure: Do missed visits matter?. Journal of Acquired Immune Deficiency Syndromes (1999) 2009, 50:100-108. 10.1097/QAI.0b013e31818d5c37.
28. Nehl E.J., He N., Wang X., Lin L., Wong F.Y., Yu F. Feasibility and willingness of using e-technologies for HIV prevention and research targeting Chinese MSM. AIDS Care 2012, 10.1080/09540121.2012.726344.
29. Parsons J.T., Golub S.A., Rosof E., Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: A randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes (1999) 2007, 46(4). 443.
30. Parsons J.T., Rosof E., Punzalan J.C., Di Maria L. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: Results of a pilot project. AIDS Patient Care and STDs 2005, 19:31-39. 10.1089/apc.2005.19.31.
31. Paterson D.L., Swindells S., Mohr J., Brester M., Vergis E.N., Squier C., et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 2000, 133:21-30.
32. Pellowski J.A., Kalichman S.C. Recent advances (2011-2012) in technology-delivered interventions for people living with HIV. Current HIV/AIDS Reports 2012, 9:326-334. http://dx.doi.org/10.1007/s11904-012-0133-9.
33. Reback C.J., Grant D.L., Fletcher J.B., Branson C.M., Shoptaw S., Bowers J.R., et al. Text messaging reduces HIV risk behaviors among methamphetamine-using men who have sex with men. AIDS and Behavior 2012, 16:1993-2002. 10.1007/s10461-012-0200-7.
34. Reif S., Mugavero M., Raper J., Thielman N., Leserman J., Whetten K., et al. Highly stressed: Stressful and traumatic experiences among individuals with HIV/AIDS in the deep south. AIDS Care 2011, 23(2):152-162.
35. Reynolds N.R., Sun J., Nagaraja H.N., Gifford A.L., Wu A.W., Chesney M.A. Optimizing measurement of self-reported adherence with the ACTG adherence questionnaire: A cross-protocol analysis. Journal of Acquired Immune Deficiency Syndromes (1999) 2007, 46:402-409.
36. Rodrigues R., Shet A., Antony J., Sidney K., Arumugam K., Krishnamurthy S., et al. Supporting adherence to antiretroviral therapy with mobile phone reminders: Results from a cohort in south India. PLoS One 2012, 7:e40723. http://dx.doi.org/10.1371/journal.pone.0040723.
37. Safren S.A., O'Cleirigh C.M., Bullis J.R., Otto M.W., Stein M.D., Pollack M.H. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology 2012, 80:404-415. http://dx.doi.org/10.1037/a0028208.
38. Sandelowski M., Voils C.I., Chang Y., Lee E.J. A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA. AIDS Care 2009, 21(8):953-966.
39. Sayles J.N., Wong M.D., Kinsler J.J., Martins D., Cunningham W.E. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. Journal of General Internal Medicine 2009, 24(10):1101-1108.
40. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry 1998, 59(Suppl. 20):22-33. [quiz 34-57].
41. Simoni J.M., Amico K.R., Pearson C.R., Malow R. Strategies for promoting adherence to antiretroviral therapy: A review of the literature. Current Infectious Disease Reports 2008, 10:515-521.
42. Simoni J.M., Pearson C.R., Pantalone D.W., Marks G., Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. Journal of Acquired Immune Deficiency Syndromes (1999) 2006, 43(Suppl 1):S23-S35. 10.1097/01.qai.0000248342.05438.52.
43. Tucker J.S., Burnam M.A., Sherbourne C.D., Kung F.Y., Gifford A.L. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine 2003, 114:573-580.
44. van der Kop M.L., Karanja S., Thabane L., Marra C., Chung M.H., Gelmon L., et al. In-depth analysis of patient-clinician cell phone communication during the WelTel Kenya1 antiretroviral adherence trial. PLoS One 2012, 7:e46033. http://dx.doi.org/10.1371/journal.pone.0046033.
45. Yannessa J.F., Reece M., Basta T.B. HIV provider perspectives: The impact of stigma on substance abusers living with HIV in a rural area of the united states. AIDS Patient Care and STDs 2008, 22(8):669-675.
46. Young S.D., Bendavid E. The relationship between HIV testing, stigma, and health service usage. AIDS Care 2010, 22(3):373-380.